A Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors

Summary

The study is being conducted to evaluate safety, tolerability, pharmacokinetics and preliminary efficacy of SHR-7787 injection monotherapy for patients with advanced solid tumors. To explore the reasonable dosage of SHR-7787 injection monotherapy for patients with advanced solid tumors.

Timeline

Start

2024-10-04

Primary completion

2026-07-31

Completion

2026-11-30

Drugs

Indications